Cargando…
Antihypertensive and cardiovascular effects of combined blockade of renin-angiotensin system with ACE inhibitor and angiotensin II type 1 receptor blocker in hypertensive patients: A 24-week randomized controlled double-dummy trial
BACKGROUND. In this study the effects of 24 weeks losartan and ramipril treatment, both alone and in combination, on blood pressure and left ventricular mass (LVM) and function, have been evaluated in hypertensives. METHODS. 57 hypertensives with stage 1 and 2 essential hypertension were included. A...
Autores principales: | ARGANO, CHRISTIANO, SCAGLIONE, ROSARIO, DI CHIARA, TIZIANA, COLOMBA, DANIELA, PARRINELLO, GASPARE, CORRAO, SALVATORE, LICATA, GIUSEPPE |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184655/ https://www.ncbi.nlm.nih.gov/pubmed/21977250 http://dx.doi.org/10.4081/hi.2006.39 |
Ejemplares similares
-
Endothelial nitric oxide synthase gene polymorphisms and cardiovascular damage in hypertensive subjects: an Italian case-control study
por: Colomba, Daniela, et al.
Publicado: (2008) -
Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
por: Mancia, Giuseppe, et al.
Publicado: (2020) -
Hypoadiponectinemia: A Link between Visceral Obesity and Metabolic Syndrome
por: Di Chiara, Tiziana, et al.
Publicado: (2012) -
Hypertension and renin-angiotensin system blockers are not associated with expression of angiotensin-converting enzyme 2 (ACE2) in the kidney
por: Jiang, Xiao, et al.
Publicado: (2020) -
Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
por: Danser, A.H. Jan, et al.
Publicado: (2020)